Micro Labs Recalls Losartan Potassium Tablets for Content Uniformity Failures
Micro Labs USA is recalling 1,440 bottles of Losartan Potassium 25 mg tablets because the dry mix failed blend uniformity specifications.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classifies this recall as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe), as it indicates a risk of temporary or medically reversible adverse health consequences.
Plain-English summary
Micro Labs USA, Inc. is recalling 1,440 bottles of Losartan Potassium Tablets USP, 25 mg, 1000 Tablet Bottles. The product is identified by NDC 42571-110-10, Lot #LJAG003, and an expiration date of 05/2015. The recall was initiated because the dry mix failed blend uniformity specifications, resulting in a failure of Content Uniformity Specifications.
The affected product was distributed in the United States, including New York. The tablets were manufactured by Micro Labs Limited in Goa, India, for Micro Labs USA, Inc. in Princeton, New Jersey.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or healthcare provider for a replacement or refund. The FDA classifies this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only. Manufactured by: Micro Labs Limited, Goa-403 722, INDIA. Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540. NDC 42571-110-10
- Manufacturer
- Micro Labs Usa, Inc S
- Category
- Drug — Prescription Medication
- Affected units
- 144
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #LJAG003
- Expiry: 05/2015
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Micro Labs Usa, Inc S
See all →- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- ModerateMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- ModerateMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Specification Failure
FDA (Drugs) · 2014-11-19
- ModerateMicro Labs Recalls Glimepiride Tablets Due to Failed Stability Testing
FDA (Drugs) · 2014-11-05
Same hazard · content uniformity
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- HighOral contraceptive tablets recalled after failing content uniformity specifications
FDA (Drugs) · 2025-10-15
- HighCefixime Oral Suspension Recalled for Failed Content Uniformity Specifications
FDA (Drugs) · 2024-06-26
- SevereFDA Recalls Phenytoin Oral Suspension Due to Content Uniformity Failure
FDA (Drugs) · 2023-12-27
- ModerateDofetilide Capsules Recalled Due to Out-of-Specification Content Uniformity
FDA (Drugs) · 2023-08-16